Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

Pop star Frankie Bridge, 37, has suffered with crippling ­depression and anxiety for ­decades. Now, she is ­proclaiming the 'life-changing' benefits of therapy using ketamine.

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...

Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for ...

Cancer rates continue to rise in Angola and across Steuben County, creating a growing need for expanded local oncology services. This expansion builds on a longstanding relationship between FWMOH and ...

If the rest of 2026 continues in this vein, we may look back on January and February as the moment the sector recognised that ...

Started in 2021, Cytokind describes itself as 'the global leader in using UVB light to treat immune disorders and improve survival and the quality of life for patients' ...

Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

Relmada Therapeutics stock surged after reporting positive Phase 2 trial results for NDV-01 and announcing a $160 million ...

Timothy McCarty, 64, knows he hasn’t taken the best care of himself. He has been smoking since he was 15 – everyone did back ...

THIS week (9-15 March) is Healthcare Science Week and an opportunity to raise the profile of the Medical Equipment Management Services (MEMS), who are the unseen heroes of keeping patient care running ...

Morris, Nada Hassanein, Shalina Chatlani and Sofia Resnick, Wisconsin Examiner March 4, 2026 Editor’s note: This is ...